CDSCO provides import license for GeneDrive Covid Testing Kits to DIVOC Health, Health News, ET HealthWorld

New Delhi: Diagnostic startup, DIVOC Health announced on Friday that it has received an import license for Genedrive 96 SARS-CoV-2 testing kits in India from India’s Central Drugs Standard Control Organisation (CDSCO).

ICMR approved, Genedrive 96 SARS-CoV-2 Kit is a novel Polymerase Chain Reaction (PCR) assay designed by molecular diagnostics Genedrive UK for detection of active infection in COVID-19 patients. The company said the decision will help it to quickly and easily detect active COVID-19 cases.

It’s in a ready-to-go solid PCR bead format that eliminates the need for reagent preparation or cold temperature storage, which makes it a more suitable solution for high-temperature countries such as India. The format simplifies laboratory workflow, allowing a patient sample to be mixed with a single bead and then tested on a variety of third-party RT-PCR platforms, said the company.

On receiving the approval, Dr. Kanav Kahol, Founder and CEO of DIVOC health said, “We thank the diagnostic division of Ministry of Health for considering our proposal and allowing us to deliver quality results to the consumers. At this time when the virus is rigorously spreading in the country, we understand that the availability of accurate and high-quality tests is critical to our fight against the pandemic, and hence, we identified the GeneDrive RT PCR COVID-19 tests as well suited to the Indian market due to its comparatively reduced processing steps, thermostability, and its high-quality manufacture.”

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.